Home
Conditions
Non-small Cell Lung Cancer

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 329 recruiting studies

Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Recruiting

Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy

NCT07014202

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer

NCT07086456

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Sun yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC

NCT07086300

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1

NCT06579196

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Recruiting

Copenhagen Master Observational Trial

NCT05145244

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Recruiting

A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC

NCT06951464

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Recruiting

Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases

NCT07008287

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC

NCT06962865

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Beijing Chest Hospital,Capital Medical Unniversity Beijing, China

The Fifth Medical Center of Chinese People's Liberation Army General Hospital Beijing, China

Binzhou Medical University Hospital Binzhou, China

Jilin Cancer Hospital Changchun, China

View all 34 locations

View Trial Details

Recruiting

Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC

NCT06379087

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC

NCT06969027

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Shandong First Medical University Affiliated Neoplasm Hospital Jinan, Shandong, China

View Trial Details

Non-small Cell Lung Cancer

Non-small Cell Lung Cancer trial results

Related conditions